This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hong Kong Baptist University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Lei Lei Chen: Innovator in Neurodegenerative Disease Treatment
Introduction: Lei Lei Chen is a prominent inventor based in Hong Kong, known for his significant contributions to the fields of pharmaceuticals, health supplements, and the chemical industries. His innovative work focuses on developing treatments for neurodegenerative diseases, offering new hope and solutions for patients.
Latest Patents: Lei Lei Chen holds one patent related to a groundbreaking herbal composition designed to counteract the Aβ increasing effects of existing treatments. This invention is particularly notable for its potential to regulate the processing of amyloid-β protein precursor (APP), resulting in a more effective treatment that is not associated with any β-amyloid increasing effects. This advancement targets neurodegenerative diseases, indicating a promising direction for future pharmaceutical innovations.
Career Highlights: Lei Lei Chen has established his career at Hong Kong Baptist University, where he focuses on research that intertwines traditional herbal medicine with modern scientific applications. His dedication to innovation in health sciences illustrates his commitment to improving health outcomes through novel therapeutic approaches.
Collaborations: Throughout his career, Chen has collaborated with notable colleagues, including Min Li and Siva Sundara Kumar Durairajan. Working alongside such esteemed professionals highlights the collaborative spirit and team-oriented approach prevalent in his research endeavors.
Conclusion: Lei Lei Chen stands out as a significant figure in the pursuit of innovative solutions for neurodegenerative diseases. With his patented herbal composition and collaborative work at Hong Kong Baptist University, he continues to contribute to the advancement of health science and offers hope for better treatment outcomes in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
